shape
Industry: Pharma / Life Sciences

Batch Record Review

Every batch record must be reviewed and released by qualified personnel within 30 days (21 CFR 211.192). StackFactor EXCEED certifies every QA reviewer on GMP and deviation analysis, and SHIELD locks down the IT controls in your QMS so only those certified reviewers can sign off on a batch.

shape
shape
shape
shape
Batch Record Review

Why Batch Reviews Miss Deadlines

21 CFR 211.192 gives QA 30 days to review and release every batch — one miss can mean a Warning Letter.

Overdue Batch Reviews

Batches sit in QA queue for weeks. FDA citations for late reviews trigger Warning Letters that halt shipments.

Missed OOS Results

Reviewers comb 200-page records for out-of-spec results. Critical deviations get buried under volume.

Unqualified Reviewer Risk

No way to prove every reviewer is GMP-certified and current. Single-point-of-failure bottlenecks stall release.

REVIEW PHASES

From Batch Close to Qualified Release

StackFactor EXCEED turns batch record review into a GMP-certified workforce capability — never an inspection surprise.

Phase 1
1

Qualified Reviewers

EXCEED certifies QA staff on GMP, OOS investigation, deviation classification, and root cause analysis — tracking currency and proficiency automatically.

EXCEED
Phase 2
2

Skill-Matched Assignments

EXCEED routes each batch to reviewers who hold the right certifications and proficiency for the product line — eliminating bottlenecks and unqualified handoffs.

EXCEED
Phase 3
3

Continuous Release Readiness

Workforce-readiness dashboards show reviewer capacity, certification currency, and training ROI — board-ready and inspection-ready.

EXCEED

Multiple Roles. One Problem.

Batch record compliance spans quality assurance, production, and manufacturing leadership. Each role has a different pain point, but they all need the same outcome.

VP Quality Assurance

FDA cited overdue batch reviews last inspection. A Warning Letter would halt shipments.

Quality Reviewer

Reviews 40+ deviations per week and misses critical OOS results buried in 200-page records.

Production Manager

Batches sit in QA queue for weeks with no visibility into what’s holding up product release.

Head of Manufacturing

Can’t prove GMP training spend is actually reducing deviations.

How EXCEED and SHIELD Work Together

Pick your role to see how the two products protect batch release from your perspective.

The Requirement

Every batch record must be reviewed and released by qualified personnel within 30 days (21 CFR 211.192).

VP Quality Assurance

Perspective
The Pain

FDA cited 3 overdue batch reviews last inspection. A Warning Letter would halt shipments.

EXCEEDEXCEED

GMP and batch review certification for every QA reviewer. Real-time visibility into who is qualified, whose training has expired, and where the gaps are.

SHIELDSHIELD

Enforces IT audit trails and access controls in your QMS and LMS so every batch sign-off is traceable to a certified reviewer.

The Insight

EXCEED ensures reviewers are qualified and current, so deviations drop at the source. SHIELD locks down the IT controls in your QMS and LMS so only those certified reviewers can release a batch — with audit-ready evidence for every inspection. Together, release stays on schedule and under compliance.

Key Benefits

GMP certification training for every QA reviewer, with proficiency measured and currency tracked automatically.

OOS investigation skill paths covering deviation classification and root cause analysis — built into every reviewer's development plan.

Skill-matched batch assignments so each batch is routed to a reviewer who is certified for the product line and current on procedures.

Workforce-capacity dashboards showing reviewer availability, certification gaps, and bottlenecks by product line.

Training ROI proof linking training hours to deviation drops and faster release cycles — board-ready evidence.

QMS audit trails and access controls enforced by SHIELD so only certified reviewers can sign off on a batch — with inspection-ready evidence.

Outcomes That Keep the FDA Away

What pharma and life sciences manufacturers see after adopting StackFactor for batch record review.

50%

Faster average review cycle

100%

On-time review rate

3x

Qualified reviewer coverage

See Batch Record Review in Action

Discover how StackFactor EXCEED keeps every QA reviewer GMP-certified and current on deviation analysis — while SHIELD locks down the IT controls in your QMS so only those certified reviewers can release a batch.

Schedule a Demo